Collectively, these studies suggest that in the absence of the growth-promoting pathways induced by ER and HER2, whether it be in the context of TNBC or cancers treated with anti-ER or HER2 therapies, Notch acts as a compensatory growth-promoting stimulus, enabling the cells to survive in the absence of these pathways (Figure 7). This evidence concerns the gene ERBB2 and cancer.